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T
he molecular analysis ofchromosomal translocations from
lymphoid malignancies and cell lines has revealed a key
role for aberrant Ig and TCR gene fusions in these rearrange-
ments (1). Analysis of such translocations has shown that
recombinase signal sequences (RSS) (2) commonly occur near
one or both chromosome breakpoints, leading to the infer-
ence that the V(D)J recombinase that recognizes these sites
is involved (1, 3). In an attempt to further our understanding
of such rearrangements, I have characterized the breakpoints
of a novel translocation from a human B cell line, which in-
volved two Ig gene clusters. The translocation arose by the
breakage and interchromosomal fusion of Ig V genes from
the L chain (x) and H chain gene clusters, surprisingly without
obvious involvement of the V(D)J recombinase. This obser-
vation leads to the suggestion that conformationally "acces-
sible" genes may have heightened susceptibility to damage
and therefore to involvement in chromosome rearrangement.
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Summary
The chromosome breakpoints of a translocation, t(2;14), from an Epstein-Barr virus-transformed
human B lymphoblastoid cell line were isolated and analyzed. This unusual translocation arose
as a result of the fusion of two immunoglobulin (Ig) variable (V) genes, one from the heavy
chain cluster on chromosome 14, the other from the light chain (x) cluster on chromosome
2. The chromosome breaks occurred within the coding sequence of each gene, and there was
no obvious evidence for lymphoid V(D)J recombinase involvement in the translocation. This
suggests that breakage and rejoining of the involved V genes occurred by some process other
than that which normally rearranges Ig genes.
Cell Line.
￿
JC11 was derived by EBV transformation of PBL
from a patient with chronic myeloid leukemia. This cell line lacked
the Ph' chromosome seen in the patient's leukemic cells, but con-
tained as the sole abnormality a noveltranslocation t(2;14)(p11;g32)
not present in the patient's blood or bone marrow cells (4).
DNA Isolation and Southern Blotting. DNA extraction and
Southern blotting were carried out as previouslydescribed (4). The
probe for JK was a 1.8-kb Sacl fragment derived from pJ-2 (a gift
from Dr. G. Bomkamm, Institute for Virology, Freiburg, Germany).
Construction and Screening ofGenomic DNA Libraries.
￿
Genomic
DNA from JC11 was digested with EcoR1, and ligated to XZAP
DNA (Stratagene, laJolla, CA). Recombinant molecules were pack-
aged in vitro, and then screened as described (5). The chromosome
14-specific genomic DNA library was obtained from the Amer-
ican Type Culture Collection, (57739; Rockville, MD).
Polymerase Chain Reaction. Oligonucleotide primers were as
follows: JCVHEX, AGGTTCCTCTTTGTGGTGGCAGCAGCT
ACA; JC11VH, TAGGATCCTGCAGTCTGGGGCTGAGGTGA-
AGAAGCCTGGG;JCVKEX, TGRTATCARCARAAACCAGG-
GRAARCYCCTA; JC11VK, TAGGATCCTCHHRRTKMAGT
RRCAGTSRATCTGGGRCA. Ambiguous baseswere: H(ACT),
K(GT), M(AC), R(AG), S(CG), Y(CT). Nested PCR (6) was car-
ried our first with JCVHEX andJCVHEX, and subsequently with
JC11VH andJC11VK. The products of this reaction were digested
with BamH1 and cloned in pBS(KS)Ml3 - (Stratagene).
DNA Sequencing.
￿
DNA sequences were established (7) using
T7 DNA polymerase with plasmids propagated in host strain DH5ot
and prepared by rapid boiling lysis (8).
Results and Discussion
We have shown that the breakpoints of the JC11 translo-
cation t(2;14) lie within the Ig VH gene cluster, and within
or upstream of the IgL Jx genes (4). Southern blots ofJC11
DNA showed that both Jtc alleles were rearranged relative
to DNA from nonlymphoid cells (Fig. 1 A). JC11 produces
functional IgL(x) chains and therefore one of the rearranged
fragments represents a productively joined Vtc-JK allele (4).
Because Jx genes are commonly involved in translocations
with 2p11 breakpoints, it seemed possible that the other rear-
ranged fragment resulted from the 14q+ breakpoint of the
t(2;14).
Molecular cloning was used to isolate the two EcoRl frag-
ments that contained rearranged Jx sequences. Recombinant
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RearrangedJK alleles ofJC11 . (A) Southern blot ofJC11DNA
(lane 1) and DNA from cells of a normal donor (lane 2) digested with
EcoRl and hybridizedwith aJK probe. RearrangedJK alleles inJC11DNA
are arrowed . The germline (gl) band in lane 2 is -10 kb in size. (B) . Re-
striction maps of plasmids containing the rearranged EcoRl fragments
from JC11 aligned with the gl JK map. Regions that are noncontiguous
with gl JK are hatched. Black bars show JK exons. Sequencing strategy
is indicated by arrows below each clone . A, Apal ; B, BamHI ; Bg, BglII ;
Bs, BstEII ; N, Ncol ; Pv, PvuII; Ps, Pstl; RI, EcoRI ; SI, Sacl ; SII, SacII ;
Sc, Scal .
plasmids containing the 5- and 3-kbEcoRl fragments (pCY15
and pCY16, respectively) were recovered and characterized
(Fig. 1 B) . The 3' map of both clones matched the germline
(gl) JK locus, but this similarity ceased 5' to JK2 in pCY15,
and 5' to JK3 in pCY16 . This suggested that both JK alleles
had undergone fusion with noncontiguousDNA. Probes from
the 5' end of each isolate detected different multiple bands
on Southern blots of digestedhumanDNA, indicating that
each came from a different family of multiple related sequences
(data not shown) . Hybridization of each probe to plaque-
lifts prepared from a genomic chromosome 14-specificDNA
library suggested that sequences in pCY16, but not pCY15
were derived from chromosome 14 (data not shown) .
The structure ofboth rearrangedJK alleles was determined
by DNA sequence analysis . The sequence ofpCY15 (Fig. 2)
revealed a fusion ofJK2 with a VK gene very similar to V6410,
a VKII family member (10) . The pCY15 VK-JK sequence has
a reading frame capable of translation into a VK L chain, and
this presumably represents the productive Ig L chain locus
ofJCll . Sequence analysis of pCY16 revealed a more com-
plex structure (Fig . 3) . Immediately 5' to JK3 is a sequence
that shows strong homology to part of a VKI gene (11). This
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Nucleotide sequence of the productive V*JK allele ofJCIL
The deduced amino acid sequence of coding regions are shown above the
nucleotide sequence, and below it are shown those bases of the V6410
VK gene (10) that differ from theJC11 VKII sequence. Deletion and inser-
tion of one nucleotide relative to V6410 are indicated by open and closed
arrowheads, respectively. Vertical arrows mark putative splice sites. The
JK2 segment is underlined. This sequence was submitted to the EMBL/Gen-
bank/DDBJ data library under the accession number X55400 .
Figure 3 .
￿
Structure of the chromo-
some 2 and 14 breakpoints of JC11 .
Breakpoint sequences from the 14q+
and 2p- of the t(2;14), aligned with
closely related Ig V genes. The VkI
(Walker) sequence is from (16), and the
f
￿
s'
￿
VHI (LR35) sequence is from (9). Gaps
have been introduced to maximize ho-
mology, and arrowheads indicate the likely breakpoints in each V gene. Two connected arrowheads above the VK sequence bracket a region apparently
deleted during the translocation . The 5' ends ofJK regions in VKI (Walker) and 14q+ are boxed . These sequences were submitted to the EMBL/Gen-
bank/DDBJ data libraries under the accession numbers X55399 (14q+) and X55398 (2p- ).
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suggests that a conventional recombinase-mediated fusion of
VK and JK elements has occurred . However, the homology
with VKI ceases abruptly 33 by 5' to the VJjunction, within
the framework (FR) III region of the VK gene . Adjacent to
the 5' end of the 32-bp VK segment is a region that shows
extensive homology to members of the VHI class of Ig H
chainV region genes (11) . This VH-like sequence is inverted
with respect to theV*JK region and it extends 5' from within
CDR2 to the heptamer and nonamer RSS, which normallyCen
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Schematic representation of the t(2;14)(p11;g32). The Ig V
genes involved are aligned in a centromere (cen)-telomere (tel) orientation
next to figures of the relevant chromosomes. Breakpoints are shown by
arrowheads. The VK-JK fusion (indicated by short vertical bars) could have
occurred before or after the translocation. PCR primers: 1, JCVKEX;
2, JC11VK; 3, JC11VH; 4, JCVHEX.
form the 3' flank of gl VH genes (Fig. 4). Homology with
gl VH extends 5' of these signal sequences for 420 by (data
not shown), beyond which no further sequence data were
obtained. Therefore, the structure of this 14q+ chromosome
breakpoint shows evidence of two distinct gene fusion events.
One appears to be a conventional V(DV recombinase-mediated
fusion between Vrc andJK segments. The other fusion is novel,
and apparently gave rise to the translocation, by joining Ig
V region genes from two different chromosomes.
To confirm the nature ofthis translocation, the breakpoint
from the 2p - chromosome was isolated. The structure of
this breakpoint was expected to be the reciprocal product of
the fusion between VH and Vrc at the 14q+ breakpoint,
which represented a unique arrangement amenable to enzy-
matic amplification by PCR. Oligonucleotide primers com-
plementary to two sites within VHI FR1 regions, and to
VKI FR2 and FR3 regions (Fig. 4), generated a 200-bp DNA
fragment from JC11 DNA, but not from three unrelated B
lymphoblastoid cell lines, when used in a nested PCR (data
not shown). The DNA sequence of the JC11-specific frag-
ment clearly showed that it was the reciprocal product of
the rearrangement seen at the 14q+ breakpoint (Fig. 3).
A comparison of the sequences of both breakpoints with
each other and with closely related Ig V genes (Fig. 3) re-
veals several features. Although the presence of the sequence
"GAT" on both chromosomes 2 and 14 means the break-
point cannot be unambiguously assigned, it seemslikely that
the VH gene has not lost any nucleotides during transloca-
tion. In contrast, 11 nucleotides of the Vic gene appear to
have been lost during the translocation process (although in
the absence of a gl sequence for this gene the precise extent
of loss cannot be determined, nor can the prior existence of
a deletion at this position be excluded). These observations
suggest that during translocation the VH gene suffered a
double-stranded DNA break, whereas the Vu gene was cleaved
by two staggered single-stranded breaks several nucleotides
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apart. Exonuclease-mediated removal of the single-stranded
extensions could account for the proposed loss of nucleotides
seen at the breakpoint. No significant matches with the con-
sensus RSS could be found in the immediate vicinity of the
breakpoints, which argues against - but does not formally
exclude - the involvement of Ig gene fusion mechanisms
in the translocation.
This t(2;14) is the first characterized example of an inter-
chromosomal fusion between Ig genes. A previously reported
t(2;14) involved H chain Ig genes but not L chain genes (12).
Chromosome rearrangements that lead to the precise fusion
of Ig and TCR elements from different clusters presumably
result from recombinase activity (1, 3). In contrast, the in-
terchromosomal fusion of Ig V genes described here does not
occur at RSS, and it more closely resembles the product of
nonspecific breakage and rejoining. Other examples of lym-
phoid translocations exist in which the breakpoints do not
occur at RSS, and in some cases, like the t(2;14) of JC11,
breakpoints lie within Ig V genes (1, 3). Therefore, aberrant
recombinase activity cannot easily account for a significant
number of lymphoid translocations, including this t(2;14),
and alternative mechanisms must be considered.
Random DNA breakage and repair by endogenous ligase
activity could account for the structure of the t(2;14).
Significantly, the patient from whom JC11 was derived had
a 16-yr history of treatment with busulfan, an alkylating agent
known to induce chromosomal abnormalities (13). PHA-
stimulated PBL from this patient showed nonclonal chro-
mosomal aberrations typical ofbusulfan-induced damage (Dr.
P. Hollings, personal communication). Therefore, it is pos-
sible that DNA damage caused by the patient's chemotherapy
may have contributed to development of the t(2;14). How-
ever, ifthis B lymphoid translocation did not result from aber-
rant V(D)J recombinase activity, why have two gene clusters
expressed exclusively in B cells been involved? One explana-
tion couldbe that those conformational features of expressed
Ig genes that are proposed to allow access by recombinase
(14) also increase susceptibility of DNA in these regions to
damage. The 14q+ breakpoint of this t(2;14) occurred
within the VH cluster of the productively rearranged Ig H
chain allele (4), and the break on chromosome 2 occurred
near to a V*JK rearrangement (Fig. 4). Therefore, both regions
involved in the translocation were presumably in an "open"
or accessible state during development of the cell that gave
rise to JC11. Genomic DNA in this state could conceivably
be more exposed to the effects of DNAdamaging agents (such
as busulfan) than DNA in regions of "closed" or inaccessible
chromatin fibers. Repair of DNA breaks could be mediated
by endogenous ligase activity or, alternatively, it is possible
that the V(D~ recombinase can preferentially fuse antigen
receptor genes that suffer spurious double-stranded DNA
breaks. This model is compatible with the observation that
translocations in various cell types tend to occur in regions
of the genome encoding differentiation-specific products (15).
Regardless of the precise mechanism involved, the break-
points described here demonstrate that Ig genes may partici-
pate in chromosome translocations of B cells without ob-
vious involvement of the V(D)J recombinase system. Thismay be related to the conformationally "open" state, which
antigen receptor genes are thought to adoptduring lymphoid
cell development (14). The derivation of the JC11 cell line
from apatient with along history oftreatment by an alkylating
agent prompts speculation that DNA damaging agents may
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